CLIN.L Share News (CLIN)

CLIN.L Information

There is currently no data for CLIN

REMOVE ADS

CLIN.L News

CORRECT: Clinigen Retakes Ethyol And Totect US Commercial Rights

(Correcting the headline to clarify that Clinigen already had the products in its portfolio).LONDON (Alliance News) - Clinigen Group PLC on Wednesday ...

Clinigen to take back US rights to cancer drugs

(Sharecast News) - Aim's Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.

Clinigen monopolises global rights for skin cancer treatment

(Sharecast News) - Clinigen now owns the global rights to Proleukin after having acquired the US rights to the treatment on Tuesday following US anti-...

Clinigen earnings grow following CSM and iQone acquisitions

(Sharecast News) - Specialty pharmaceuticals group Clinigen saw strong earnings and cash flow growth in the first half of its trading year following a...

Clinigen Group Reports "Good" Interim Performance As Revenue Rises

LONDON (Alliance News) - Clinigen Group PLC on Wednesday described its interim performance as "good", with revenue rising 24%, but profit did fall on ...